Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6284)
All Articles published online
|
May 14, 2009 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Choi D, Lee HW, Hur KY, Kim JJ, Park GS, Jang SH, Song YS, Jang KS, Paik SS. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 2009; 15(18): 2258-2264 [PMID: 19437567 DOI: 10.3748/wjg.15.2258] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i18/2258.htm |
| Number | Citing Articles |
| 1 |
Xianfeng Fang, Pan Zheng, Jie Tang, Yang Liu. CD24: from A to Z. Cellular & Molecular Immunology 2010; 7(2): 100 doi: 10.1038/cmi.2009.119
|
| 2 |
S Buczacki, R J Davies, D J Winton. Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target. British Journal of Cancer 2011; 105(9): 1253 doi: 10.1038/bjc.2011.362
|
| 3 |
Brijnandan Gupta, Prasenjit Das, Shouriyo Ghosh, Janvie Manhas, Sudip Sen, Sujoy Pal, Peush Sahni, Aashish Dutt Upadhyay, Subrat K. Panda, Siddhartha Datta Gupta. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers. Clinical Colorectal Cancer 2017; 16(3): 204 doi: 10.1016/j.clcc.2016.09.001
|
| 4 |
Shirin Mahmoodi, Navid Nezafat, Manica Negahdaripour, Younes Ghasemi. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties. Current Molecular Medicine 2019; 19(1): 2 doi: 10.2174/1566524019666190204114721
|
| 5 |
Pina Ziranu, Valentina Aimola, Andrea Pretta, Marco Dubois, Raffaele Murru, Nicole Liscia, Flaviana Cau, Mara Persano, Giulia Deias, Enrico Palmas, Francesco Loi, Marco Migliari, Valeria Pusceddu, Marco Puzzoni, Eleonora Lai, Stefano Cascinu, Gavino Faa, Mario Scartozzi. New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression. Cancers 2023; 15(4): 1212 doi: 10.3390/cancers15041212
|
| 6 |
Saleh Ramezani, Arianna Parkhideh, Pratip K. Bhattacharya, Mary C. Farach-Carson, Daniel A. Harrington. Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.657701
|
| 7 |
Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, Margaret Green, Alan M. Seddon, Helmout Modjtahedi. Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer. Oncotarget 2019; 10(18): 1704 doi: 10.18632/oncotarget.26722
|
| 8 |
Gokulan Ravindran, Halagowder Devaraj. Aberrant expression of CD133 and musashi‐1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors. Head & Neck 2012; 34(8): 1129 doi: 10.1002/hed.21896
|
| 9 |
Lulu Farhana, Pratima Nangia-Makker, Evan Arbit, Kathren Shango, Sarah Sarkar, Hamidah Mahmud, Timothy Hadden, Yingjie Yu, Adhip P. N. Majumdar. Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Research & Therapy 2016; 7(1) doi: 10.1186/s13287-016-0439-4
|
| 10 |
Nerea Bitarte, Eva Bandres, Valentina Boni, Ruth Zarate, Javier Rodriguez, Marisol Gonzalez-Huarriz, Ines Lopez, Jesus Javier Sola, Marta M. Alonso, Puri Fortes, Jesus Garcia-Foncillas. MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells. Stem Cells 2011; 29(11): 1661 doi: 10.1002/stem.741
|
| 11 |
Fabian Lang, Bartosch Wojcik, Michael A. Rieger. Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia. Stem Cells International 2015; 2015: 1 doi: 10.1155/2015/137164
|
| 12 |
Ke Wang, Jianjun Xu, Junshu Zhang, Jian Huang. Prognostic role of CD133 expression in colorectal cancer: a meta-analysis. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-573
|
| 13 |
A. P. Davydov-Sinitsyn, O. V. Bajenova, M. A. Liskovykh, S. V. Ponomartsev, I. V. Rykov, S. A. Koshkin, R. V. Orlova, A. N. Tomilin, E. N. Tolkunova. Tumor growth suppression after xenografting of human colorectal carcinoma cells. Cell and Tissue Biology 2015; 9(4): 318 doi: 10.1134/S1990519X15040045
|
| 14 |
Rongyong Huang, Dan Mo, Junrong Wu, Huaying Ai, Yiping Lu. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients. Medicine 2018; 97(23): e10446 doi: 10.1097/MD.0000000000010446
|
| 15 |
Kathryn E. Hamilton, Felicite K. Noubissi, Prateek S. Katti, Christopher M. Hahn, Sonya R. Davey, Emma T. Lundsmith, Andres J. Klein-Szanto, Andrew D. Rhim, Vladimir S. Spiegelman, Anil K. Rustgi. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts. Carcinogenesis 2013; 34(11): 2647 doi: 10.1093/carcin/bgt217
|
| 16 |
Danysh Abetov, Zhanar Mustapova, Timur Saliev, Denis Bulanin. Biomarkers and signaling pathways of colorectal cancer stem cells. Tumor Biology 2015; 36(3): 1339 doi: 10.1007/s13277-015-3198-4
|
| 17 |
Aristides G. Vaiopoulos, Ioannis D. Kostakis, Michael Koutsilieris, Athanasios G. Papavassiliou. Colorectal Cancer Stem Cells. STEM CELLS 2012; 30(3): 363 doi: 10.1002/stem.1031
|
| 18 |
Afshin Habibi, Nastaran Ranjbari, Fakher Rahim, Nematollah Jazayeri. Correlation between CD34 Marker and Clinico-Pathologic Characteristics of Gastric Cancer. International Journal of Cancer Research 2015; 11(3): 136 doi: 10.3923/ijcr.2015.136.142
|
| 19 |
Matilde Todaro, Maria Giovanna Francipane, Jan Paul Medema, Giorgio Stassi. Colon Cancer Stem Cells: Promise of Targeted Therapy. Gastroenterology 2010; 138(6): 2151 doi: 10.1053/j.gastro.2009.12.063
|
| 20 |
SHU‐CHUAN TSAO, CHUN‐CHIEH WU, CHIEN‐HUI WEN, YA‐CHUN HUANG, CHEE‐YIN CHAI. A simple and economical method for the manual construction of frozen tissue arrays. APMIS 2010; 118(10): 739 doi: 10.1111/j.1600-0463.2010.02652.x
|
| 21 |
Yalan Bi, Yunxiao Meng, Huanwen Wu, Quancai Cui, Yufeng Luo, Xiaowei Xue. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten‐year follow‐up and prognostic analysis. Journal of Surgical Oncology 2016; 113(2): 144 doi: 10.1002/jso.24124
|
| 22 |
Lucinei R. Oliveira, João P. Oliveira-Costa, Iana M. Araujo, Danilo F. Soave, Juliana S. Zanetti, Fernando A. Soares, Sérgio Zucoloto, Alfredo Ribeiro-Silva. Cancer stem cell immunophenotypes in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 2011; 40(2): 135 doi: 10.1111/j.1600-0714.2010.00967.x
|
| 23 |
Yijun Hu, Xiya Yu, Shupeng Liu, Shanrong Liu. Cancer stem cells: A shifting subpopulation of cells with stemness?. Medical Hypotheses 2013; 80(5): 649 doi: 10.1016/j.mehy.2013.01.009
|
| 24 |
Amy V. Paschall, Dafeng Yang, Chunwan Lu, Priscilla S. Redd, Jeong-Hyeon Choi, Christopher M. Heaton, Jeffrey R. Lee, Asha Nayak-Kapoor, Kebin Liu. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype. Oncotarget 2016; 7(48): 78698 doi: 10.18632/oncotarget.12168
|
| 25 |
D. Spiegelberg, G. Kuku, R. Selvaraju, M. Nestor. Characterization of CD44 variant expression in head and neck squamous cell carcinomas. Tumor Biology 2014; 35(3): 2053 doi: 10.1007/s13277-013-1272-3
|
| 26 |
Crende Olatz, García-Gallastegui Patricia, Luzuriaga Jon, Badiola Iker, de la Hoz Carmen, Unda Fernando, Ibarretxe Gaskon, Pineda Jose Ramon. Is There Such a Thing as a Genuine Cancer Stem Cell Marker? Perspectives from the Gut, the Brain and the Dental Pulp. Biology 2020; 9(12): 426 doi: 10.3390/biology9120426
|
| 27 |
FEIFENG JING, HUN JIN KIM, CHANG HYUN KIM, YOUNG JIN KIM, JAE HYUK LEE, HYEONG ROK KIM. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. International Journal of Oncology 2015; 46(4): 1582 doi: 10.3892/ijo.2015.2844
|
| 28 |
M A H Ahmed, A Al-Attar, J Kim, N F S Watson, J H Scholefield, L G Durrant, M Ilyas. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer. Journal of Clinical Pathology 2009; 62(12): 1117 doi: 10.1136/jcp.2009.069310
|
| 29 |
Yang Zhao, Jing Peng, Enlong Zhang, Ning Jiang, Jiang Li, Qi Zhang, Xuening Zhang, Yuanjie Niu. CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis. Oncotarget 2016; 7(9): 10023 doi: 10.18632/oncotarget.7054
|
| 30 |
Jaromir Hacek, Antonin Brisuda, Marek Babjuk, Josef Zamecnik. Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions. Biomedical Papers 2021; 165(3): 316 doi: 10.5507/bp.2020.017
|
| 31 |
Youness Azimzade, Abbas Ali Saberi, Muhammad Sahimi. Role of the Interplay Between the Internal and External Conditions in Invasive Behavior of Tumors. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24418-8
|
| 32 |
Yuichiro Hatano, Shinya Fukuda, Kenji Hisamatsu, Akihiro Hirata, Akira Hara, Hiroyuki Tomita. Multifaceted Interpretation of Colon Cancer Stem Cells. International Journal of Molecular Sciences 2017; 18(7): 1446 doi: 10.3390/ijms18071446
|
| 33 |
Aneet Mann, Randy van Ommeren, Branavan Manoranjan, Nicole McFarlane, Parvez Vora, Chitra Venugopal, Sheila Singh. Cancer Stem Cells. 2014; : 193 doi: 10.1002/9781118356203.ch15
|
| 34 |
Youn Young Park, Chang Hyeok An, Seong Taek Oh, Eun Deock Chang, Jaeim Lee. Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma. Medicine 2019; 98(32): e16709 doi: 10.1097/MD.0000000000016709
|
| 35 |
Ning Su, Liang Peng, Bingqing Xia, Yingying Zhao, Angao Xu, Jing Wang, Xinying Wang, Bo Jiang. Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer. Molecular Cancer 2012; 11(1) doi: 10.1186/1476-4598-11-43
|
| 36 |
Sun Young Moon, Minjoo Han, Gyoungah Ryu, Seong-Ah Shin, Jun Hyuck Lee, Chang Sup Lee. Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200. International Journal of Molecular Sciences 2023; 24(20): 15072 doi: 10.3390/ijms242015072
|
| 37 |
Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, Jie Chai, Jing Hao. Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription. Molecular Cancer Research 2023; 21(2): 115 doi: 10.1158/1541-7786.MCR-22-0134
|
| 38 |
April Adams, Kristy Warner, Alexander T. Pearson, Zhaocheng Zhang, Hong Sun Kim, Daiki Mochizuki, Gregory Basura, Joseph Helman, Andrea Mantesso, Rogério M. Castilho, Max S. Wicha, Jacques E. Nör. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas. Oncotarget 2015; 6(29): 26633 doi: 10.18632/oncotarget.5782
|
| 39 |
Lin Jin, Trung Vu, Guandou Yuan, Pran K. Datta. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway. Cancer Research 2017; 77(20): 5464 doi: 10.1158/0008-5472.CAN-17-0286
|
| 40 |
S.M. Riajul Wahab, Farhadul Islam, Vinod Gopalan, Alfred King-yin Lam. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer. Clinical Colorectal Cancer 2017; 16(2): 93 doi: 10.1016/j.clcc.2017.01.011
|
| 41 |
Fatemeh B. Rassouli, Maryam M. Matin, Morvarid Saeinasab. Cancer stem cells in human digestive tract malignancies. Tumor Biology 2016; 37(1): 7 doi: 10.1007/s13277-015-4155-y
|
| 42 |
Safia Salaria, Anna Means, Frank Revetta, Kamran Idrees, Eric Liu, Chanjuan Shi. Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors. American Journal of Clinical Pathology 2015; 144(4): 642 doi: 10.1309/AJCPMZY5P9TWNJJV
|
| 43 |
Julie Pannequin. Cellules souches cancéreuses et cancer du côlon. Bulletin du Cancer 2017; 104(12): 1072 doi: 10.1016/j.bulcan.2017.10.016
|
| 44 |
Danilo Figueiredo Soave, João Paulo Oliveira da Costa, Giorgia Gobbi da Silveira, Renata Carolina Fraga Ianez, Lucinei Roberto de Oliveira, Silvia Vanessa Lourenço, Alfredo Ribeiro-Silva. CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms. Diagnostic Pathology 2013; 8(1) doi: 10.1186/1746-1596-8-29
|
| 45 |
Juanjuan Ou, Jia Deng, Xing Wei, Ganfeng Xie, Rongbin Zhou, Liqing Yu, Houjie Liang. Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells. Stem Cell Research 2013; 11(2): 820 doi: 10.1016/j.scr.2013.05.009
|
| 46 |
Ryo Seishima, Koji Okabayashi, Osamu Nagano, Hirotoshi Hasegawa, Masashi Tsuruta, Masayuki Shimoda, Kaori Kameyama, Hideyuki Saya, Yuko Kitagawa. Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9+ cancer stem cells in ulcerative colitis-related cancer. Clinics and Research in Hepatology and Gastroenterology 2016; 40(4): 487 doi: 10.1016/j.clinre.2015.11.007
|
| 47 |
Thomas B. Brunner, Leoni A. Kunz-Schughart, Philipp Grosse-Gehling, Michael Baumann. Cancer Stem Cells as a Predictive Factor in Radiotherapy. Seminars in Radiation Oncology 2012; 22(2): 151 doi: 10.1016/j.semradonc.2011.12.003
|
| 48 |
Alessandro Sgambato, Maddalena Corbi, Maria Svelto, Emanuele Caredda, Achille Cittadini. Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology. Advances in Experimental Medicine and Biology 2013; 777: 145 doi: 10.1007/978-1-4614-5894-4_10
|
| 49 |
Yuehua Gong, Ying Guo, Yanan Hai, Hao Yang, Yang Liu, Shi Yang, Zhenzhen Zhang, Meng Ma, Linhong Liu, Zheng Li, Zuping He. Nodal Promotes the Self-Renewal of Human Colon Cancer Stem Cells via an Autocrine Manner through Smad2/3 Signaling Pathway. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/364134
|
| 50 |
Antonija Kreso, Liane Gibson, Catherine Adell O’Brien. Metastasis of Colorectal Cancer. Cancer Metastasis - Biology and Treatment 2010; 14: 127 doi: 10.1007/978-90-481-8833-8_5
|
| 51 |
Shicai Chen, Xinming Song, Zhihui Chen, Xinxin Li, Mingzhe Li, Haiying Liu, Jianchang Li, Hiromu Suzuki. CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis. PLoS ONE 2013; 8(2): e56380 doi: 10.1371/journal.pone.0056380
|
| 52 |
Yang-Hong Ni, Xia Zhao, Wei Wang. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy. Current Gene Therapy 2020; 20(2): 109 doi: 10.2174/1566523220666200623170738
|
| 53 |
Mohamed L. Salem, Ahmed S. El-Badawy, Zihai Li. Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy. Cytotechnology 2015; 67(5): 749 doi: 10.1007/s10616-014-9830-0
|
| 54 |
V. Moreno García, J. F. Batlle, E. Casado, E. Burgos, J. de Castro, C. Belda, J. Barriuso, J. J. Sánchez, M. Á. García-Cabezas, M. González-Barón, P. Cejas. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy. Colorectal Disease 2011; 13(9): 989 doi: 10.1111/j.1463-1318.2010.02386.x
|
| 55 |
Yumin Chung, Young Chan Wi, Yeseul Kim, Seong Sik Bang, Jung-Ho Yang, Kiseok Jang, Kyueng-Whan Min, Seung Sam Paik. The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma. Journal of Pathology and Translational Medicine 2018; 52(1): 37 doi: 10.4132/jptm.2017.10.20
|
| 56 |
Po Zhao, Yazhuo Li, Yali Lu. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-218
|
| 57 |
Morteza Akbari, Navid Shomali, Afsaneh Faraji, Dariush Shanehbandi, Milad Asadi, Ahad Mokhtarzadeh, Aliakbar Shabani, Behzad Baradaran. CD133: An emerging prognostic factor and therapeutic target in colorectal cancer. Cell Biology International 2020; 44(2): 368 doi: 10.1002/cbin.11243
|
| 58 |
Arianna Casciati, Mirella Tanori, Rémi Manczak, Sofiane Saada, Barbara Tanno, Paola Giardullo, Elena Porcù, Elena Rampazzo, Luca Persano, Giampietro Viola, Claire Dalmay, Fabrice Lalloué, Arnaud Pothier, Caterina Merla, Mariateresa Mancuso. Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype. Cancers 2020; 12(1): 226 doi: 10.3390/cancers12010226
|
| 59 |
Juntao Lang, Xiaoli Lan, Yu Liu, Xueyan Jin, Tao Wu, Xun Sun, Qiong Wen, Rui An. Targeting cancer stem cells with an 131 I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts. Nuclear Medicine and Biology 2015; 42(5): 505 doi: 10.1016/j.nucmedbio.2015.01.003
|
| 60 |
S. Ramalingam, G. W. Daughtridge, M. J. Johnston, A. D. Gracz, S. T. Magness. Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(1): G10 doi: 10.1152/ajpgi.00277.2011
|
| 61 |
Junko Kishikawa, Shinsuke Kazama, Koji Oba, Kiyoshi Hasegawa, Hiroyuki Anzai, Yuzo Harada, Hiroyuki Abe, Keisuke Matsusaka, Kumiko Hongo, Masaru Oba, Koji Yasuda, Kensuke Otani, Takeshi Nishikawa, Toshiaki Tanaka, Junichiro Tanaka, Tomomichi Kiyomatsu, Keisuke Hata, Kazushige Kawai, Hiroaki Nozawa, Hironori Yamaguchi, Soichiro Ishihara, Eiji Sunami, Tetsuo Ushiku, Joji Kitayama, Masashi Fukayama, Norihiro Kokudo, Toshiaki Watanabe. CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis. Annals of Surgical Oncology 2016; 23(6): 1916 doi: 10.1245/s10434-016-5099-1
|
| 62 |
Morteza Ghanadpour, Fatemeh Bossaghzadeh, Hamid Galehdari, Seyed Reza Kazemi Nezhad, Maryam Tahmasebi-Birgani, Mohammadreza Hajjari. Overexpression and Downregulation of HOTAIR Influence the Stemness Markers in Gastric Cancer Cell Lines. Gene, Cell and Tissue 2024; 11(2) doi: 10.5812/gct-144068
|
| 63 |
V Boncheva, S A Bonney, S E Brooks, M Tangney, G O'Sullivan, A Mirnezami, B-A Guinn. New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?. Cancer Gene Therapy 2013; 20(3): 157 doi: 10.1038/cgt.2013.5
|
| 64 |
Jin-Hai Zhai, Wen-Chao Gu, Xiao-Lin Xu, Jiang Wu, Xue-Jun Hu, Ke-Zhu Hou. RETRACTED ARTICLE: Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis. Tumor Biology 2015; 36(2): 701 doi: 10.1007/s13277-014-2251-z
|
| 65 |
Kai Zhao, Caifeng Wu, Xiangjun Li, Mengchao Niu, Dan Wu, Xiaofeng Cui, Hai Zhao. From mechanism to therapy: the journey of CD24 in cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1401528
|
| 66 |
Xiao-Song Wu, Hong-Qing Xi, Lin Chen. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-244
|
| 67 |
Alireza Mirzaei, Gholamreza Tavoosidana, Mohammad Hossein Modarressi, Afshin Abdi Rad, Mohammad Sadegh Fazeli, Reza Shirkoohi, Masoumeh Tavakoli-Yaraki, Zahra Madjd. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Tumor Biology 2015; 36(6): 4801 doi: 10.1007/s13277-015-3132-9
|
| 68 |
S. Di Franco, M. Todaro, F. Dieli, G. Stassi. Colorectal cancer defeating? Challenge accepted!. Molecular Aspects of Medicine 2014; 39: 61 doi: 10.1016/j.mam.2013.07.001
|
| 69 |
Cristina Maccalli, Andrea Volontè, Carolina Cimminiello, Giorgio Parmiani. Immunology of cancer stem cells in solid tumours. A review. European Journal of Cancer 2014; 50(3): 649 doi: 10.1016/j.ejca.2013.11.014
|
| 70 |
Mehran Pashirzad, Thozhukat Sathyapalan, Afsana Sheikh, Prashant Kesharwani, Amirhossein Sahebkar. Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer. Process Biochemistry 2022; 115: 19 doi: 10.1016/j.procbio.2022.02.006
|
| 71 |
Karen Bento Ribeiro, Juliana da Silva Zanetti, Alfredo Ribeiro-Silva, Liane Rapatoni, Harley Francisco de Oliveira, Daniela Pretti da Cunha Tirapelli, Sergio Britto Garcia, Omar Feres, José Joaquim Ribeiro da Rocha, Fernanda Maris Peria. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer. Cancer Biomarkers 2016; 16(4): 513 doi: 10.3233/CBM-160592
|
| 72 |
Sweta Suman, Subhransu Kumar Hota, Pranati Misra, Nageswar Sahu, Subrat Sahu. Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma. Cureus 2023; doi: 10.7759/cureus.41242
|
| 73 |
Sumei Lu, Jiajun Tian, Zhenghua Lv, Haibo Wang, Xiaohui Bai, Wenwen Liu, Jianfeng Li, Wei Xu. The Probable Role of Tumor Stem Cells for Lymph Node Metastasis in Supraglottic Carcinoma. Pathology & Oncology Research 2011; 17(1): 33 doi: 10.1007/s12253-010-9271-9
|
| 74 |
Nobuhiro Torata, Kenoki Ohuchida, Shin Akagawa, Lin Cui, Shingo Kozono, Kazuhiro Mizumoto, Shinichi Aishima, Yoshinao Oda, Masao Tanaka. Tissue tablet method: an efficient tissue banking procedure applicable to both molecular analysis and frozen tissue microarray. Human Pathology 2014; 45(1): 143 doi: 10.1016/j.humpath.2013.08.013
|
| 75 |
Margaret L. Thomas, Krysta M. Coyle, Mohammad Sultan, Paola Marcato. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. 2015; : 477 doi: 10.1007/978-3-319-21030-8_17
|
| 76 |
Appalaraju Jaggupilli, Eyad Elkord. Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/708036
|
| 77 |
Sara Häggblad Sahlberg, Diana Spiegelberg, Bengt Glimelius, Bo Stenerlöw, Marika Nestor, Andrew Yeudall. Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells. PLoS ONE 2014; 9(4): e94621 doi: 10.1371/journal.pone.0094621
|
| 78 |
Han Han, Ting He, Yingfan Wu, Tianmei He, Weiqiang Zhou. Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1441081
|
| 79 |
Sonya A Hubbard, Caroline E Gargett. A cancer stem cell origin for human endometrial carcinoma?. REPRODUCTION 2010; 140(1): 23 doi: 10.1530/REP-09-0411
|
| 80 |
KEITA TODOROKI, SACHIKO OGASAWARA, JUN AKIBA, MASAMICHI NAKAYAMA, YOSHIKI NAITO, NAOKO SEKI, JINGO KUSUKAWA, HIROHISA YANO. CD44v3+/CD24− cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. International Journal of Oncology 2016; 48(1): 99 doi: 10.3892/ijo.2015.3261
|
| 81 |
Ran Wei, Jichuan Quan, Shuofeng Li, Hengchang Liu, Xu Guan, Zheng Jiang, Xishan Wang. Integrative Analysis of Biomarkers Through Machine Learning Identifies Stemness Features in Colorectal Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.724860
|
| 82 |
Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong. The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00309
|
| 83 |
Xiaohui Wang, Wei Qiu, Haoyu Liu, Tian Li, Hua Ye, Yateng Li, Xiang Xu, Ping Chen. The prognostic value of combining CD133 and mismatch repair proteins in patients with colorectal cancer. Clinical and Experimental Pharmacology and Physiology 2021; 48(1): 54 doi: 10.1111/1440-1681.13408
|
| 84 |
Kumiko Hongo, Junichiro Tanaka, Nelson H. Tsuno, Kazushige Kawai, Takeshi Nishikawa, Yasutaka Shuno, Kazuhito Sasaki, Manabu Kaneko, Masaya Hiyoshi, Eiji Sunami, Joji Kitayama, Koki Takahashi, Hirokazu Nagawa. CD133(−) Cells, Derived From a Single Human Colon Cancer Cell Line, Are More Resistant to 5-Fluorouracil (FU) Than CD133(+) Cells, Dependent on the β1-Integrin Signaling. Journal of Surgical Research 2012; 175(2): 278 doi: 10.1016/j.jss.2011.03.076
|
| 85 |
Seung Yeop Oh, Se Hwa Sohn, Hyunee Yim, Dakeun Lee, Kwang Wook Suh, Young Bae Kim. ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer. Journal of Surgical Oncology 2015; 111(2): 243 doi: 10.1002/jso.23792
|
| 86 |
Xiaolong Wei, David Dombkowski, Katia Meirelles, Rafael Pieretti-Vanmarcke, Paul P. Szotek, Henry L. Chang, Frederic I. Preffer, Peter R. Mueller, Jose Teixeira, David T. MacLaughlin, Patricia K. Donahoe. Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proceedings of the National Academy of Sciences 2010; 107(44): 18874 doi: 10.1073/pnas.1012667107
|
| 87 |
Jeffrey B. King, Richard J. von Furstenberg, Brian J. Smith, Kirk K. McNaughton, Joseph A. Galanko, Susan J. Henning. CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(4): G443 doi: 10.1152/ajpgi.00087.2012
|
| 88 |
Maria Giovanna Francipane, Denis Bulanin, Eric Lagasse. Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure. International Journal of Molecular Sciences 2019; 20(8): 1817 doi: 10.3390/ijms20081817
|
| 89 |
Shinsuke Kazama, Junko Kishikawa, Tomomichi Kiyomatsu, Kazushige Kawai, Hiroaki Nozawa, Soichiro Ishihara, Toshiaki Watanabe. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis. Asian Journal of Surgery 2018; 41(3): 274 doi: 10.1016/j.asjsur.2016.12.002
|
| 90 |
L Florianova, M Orain, B Têtu, CJ Doillon. Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease. Biotechnic & Histochemistry 2013; 88(5): 222 doi: 10.3109/10520295.2012.758310
|
| 91 |
Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lianfang Yang, Jiuqing Xie, Xiaotao Li, Wenwei Qiu, Zhengfang Yi, Mingyao Liu. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1392-8
|
| 92 |
Peng-Cheng Yu, Di Liu, Zeng-Xiang Han, Fang Liang, Cui-Yun Hao, Yun-Tao Lei, Chang-Run Guo, Wen-Hui Wang, Xing-Hua Li, Xiao-Na Yang, Chang-Zhu Li, Ye Yu, Ying-Zhe Fan. Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.779715
|
| 93 |
Rashmi K Ambasta, Archita Sharma, Pravir Kumar. Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy. Vascular Cell 2011; 3(1): 26 doi: 10.1186/2045-824X-3-26
|
| 94 |
A Lugli, G Iezzi, I Hostettler, M G Muraro, V Mele, L Tornillo, V Carafa, G Spagnoli, L Terracciano, I Zlobec. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. British Journal of Cancer 2010; 103(3): 382 doi: 10.1038/sj.bjc.6605762
|
| 95 |
Chih‐Yung Yang, Chi‐Hung Lin, Jeng‐Kai Jiang. Early relapse in a rectal cancer patient: Possible implication of circulating cancer stem cell. Journal of Surgical Oncology 2010; 102(2): 196 doi: 10.1002/jso.21597
|
| 96 |
Larissa Belov, Jerry Zhou, Richard I. Christopherson. Cell Surface Markers in Colorectal Cancer Prognosis. International Journal of Molecular Sciences 2010; 12(1): 78 doi: 10.3390/ijms12010078
|
| 97 |
KAZUAKI HIROISHI, MASAFUMI INOMATA, KENJI KASHIMA, KAZUHIRO YASUDA, NORIO SHIRAISHI, SHIGEO YOKOYAMA, SEIGO KITANO. Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer. Experimental and Therapeutic Medicine 2011; 2(3): 465 doi: 10.3892/etm.2011.243
|
| 98 |
Hossein Keymoosi, Elmira Gheytanchi, Mojgan Asgari, Ahmad Shariftabrizi, Zahra Madjd. ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder. Asian Pacific Journal of Cancer Prevention 2014; 15(5): 2013 doi: 10.7314/APJCP.2014.15.5.2013
|
| 99 |
Shashikant Singh, Minakshi Bhardwaj, Amita Sen, Kaniyappan Nambiyar, Arvind Ahuja. Cancer Stem Cell Markers — CD133 and CD44 — in Paediatric Solid Tumours: A Study of Immunophenotypic Expression and Correlation with Clinicopathological Parameters. Indian Journal of Surgical Oncology 2023; 14(1): 113 doi: 10.1007/s13193-022-01626-3
|
| 100 |
Kumiko Hongo, Shinsuke Kazama, Eiji Sunami, Nelson H. Tsuno, Koki Takahashi, Hirokazu Nagawa, Joji Kitayama. Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer. Medical Oncology 2012; 29(4): 2849 doi: 10.1007/s12032-012-0161-8
|
| 101 |
Injae Hong, Seong Woo Hong, Yeo Goo Chang, Woo Yong Lee, Byungmo Lee, Yun Kyung Kang, You Sun Kim, In Wook Paik, Hyucksang Lee. Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis. Annals of Coloproctology 2015; 31(3): 84 doi: 10.3393/ac.2015.31.3.84
|
| 102 |
Guangqiu Li, Chao Liu, Jian Yuan, Xiaoqin Xiao, Na Tang, Junmei Hao, Hongwei Wang, Xiuwu Bian, Yongjian Deng, Yanqing Ding. CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential. Clinical & Experimental Metastasis 2010; 27(7): 517 doi: 10.1007/s10585-010-9341-0
|
| 103 |
Shan-Shan Zhang, Zai-Wei Huang, Li-Xuan Li, Jin-Jin Fu, Bing Xiao. Identification of CD200+ colorectal cancer stem cells and their gene expression profile. Oncology Reports 2016; 36(4): 2252 doi: 10.3892/or.2016.5039
|
| 104 |
Stepan Nersisyan, Ann-Kristin Ahlers, Tobias Lange, Daniel Wicklein, Alexei Galatenko, Hanibal Bohnenberger, Omar Elakad, Lena-Christin Conradi, Sandra Genduso, Hanna Maar, Alina Schiecke, Diana Maltseva, Maria Raygorodskaya, Julia Makarova, Udo Schumacher, Alexander Tonevitsky. Low expression of CD24 is associated with poor survival in colorectal cancer. Biochimie 2022; 192: 91 doi: 10.1016/j.biochi.2021.10.004
|
| 105 |
Mitra Mehrazma, Zahra Madjd, Elham Kalantari, Mahshid Panahi, Alireza Hendi, Ahmad Shariftabrizi. Expression of Stem Cell Markers, CD133 and CD44, in Pediatric Solid Tumors: A Study Using Tissue Microarray. Fetal and Pediatric Pathology 2013; 32(3): 192 doi: 10.3109/15513815.2012.701266
|
| 106 |
Christina Karamboulas, Laurie Ailles. Developmental signaling pathways in cancer stem cells of solid tumors. Biochimica et Biophysica Acta (BBA) - General Subjects 2013; 1830(2): 2481 doi: 10.1016/j.bbagen.2012.11.008
|
| 107 |
Papori Neog Bora, Vishwa Jyoti Baruah, Surajit Borkotokey, Loyimee Gogoi, Priyakshi Mahanta, Ankumon Sarmah, Rajnish Kumar, Stefano Moretti. Identifying the Salient Genes in Microarray Data: A Novel Game Theoretic Model for the Co-Expression Network. Diagnostics 2020; 10(8): 586 doi: 10.3390/diagnostics10080586
|
| 108 |
S.S. Mitra, J.Q. He, R. Esparza, G. Hutter, S.H. Cheshier, I. Weissman. Cancer Stem Cells. 2016; : 3 doi: 10.1016/B978-0-12-803892-5.00001-2
|
| 109 |
Hyuk Hur, Inna Tulina, Min Soo Cho, Byung Soh Min, Woong Sub Koom, Joon Seok Lim, Joong Bae Ahn, Nam Kyu Kim. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis. Diseases of the Colon & Rectum 2016; 59(12): 1174 doi: 10.1097/DCR.0000000000000711
|
| 110 |
Haobin Zhao, Ruining Han, Zhankun Wang, Junfang Xian, Xiaosu Bai. Colorectal Cancer Stem Cells and Targeted Agents. Pharmaceutics 2023; 15(12): 2763 doi: 10.3390/pharmaceutics15122763
|
| 111 |
YUHANG MA, XUEJIAO WANG, YONGDE PENG, XIAOYING DING. Forkhead box O1 promotes INS-1 cell apoptosis by reducing the expression of CD24. Molecular Medicine Reports 2016; 13(4): 2991 doi: 10.3892/mmr.2016.4896
|
| 112 |
Shilpa Ravindran, Saad Rasool, Cristina Maccalli. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy. Cancer Microenvironment 2019; 12(2-3): 133 doi: 10.1007/s12307-019-00233-1
|
| 113 |
Giuditta Mannelli, Oreste Gallo. Cancer stem cells hypothesis and stem cells in head and neck cancers. Cancer Treatment Reviews 2012; 38(5): 515 doi: 10.1016/j.ctrv.2011.11.007
|
| 114 |
Dina Mohamed Abdallah, Haitham Badawy, Shady Fadel, Hazem El Akaad. The expression of stem cell markers CD133 and Nestin in peripheral neuroblastic tumors. Egyptian Journal of Pathology 2011; 31(2): 118 doi: 10.1097/01.XEJ.0000406596.11732.fb
|
| 115 |
M Ozawa, Y Ichikawa, Y-W Zheng, T Oshima, H Miyata, K Nakazawa, H-B Guan, M Shiozawa, M Akaike, K Watanabe, M Ota, S Fujii, C Kunisaki, T Ishikawa, K Tanaka, H Akiyama, I Endo, H Taniguchi. Prognostic significance of CD44 variant 2 upregulation in colorectal cancer. British Journal of Cancer 2014; 111(2): 365 doi: 10.1038/bjc.2014.253
|
| 116 |
Sergei A. Koshkin, Olga V. Anatskaya, Alexander E. Vinogradov, Vladimir N. Uversky, Guy W. Dayhoff, Margarita A. Bystriakova, Valery A. Pospelov, Elena N. Tolkunova. Isolation and Characterization of Human Colon Adenocarcinoma Stem-Like Cells Based on the Endogenous Expression of the Stem Markers. International Journal of Molecular Sciences 2021; 22(9): 4682 doi: 10.3390/ijms22094682
|
| 117 |
Antonio Ieni, Giovanni Tuccari. Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer". Journal of Breast Cancer 2016; 19(1): 96 doi: 10.4048/jbc.2016.19.1.96
|
| 118 |
Saad Rasool, Sergio Rutella, Soldano Ferrone, Cristina Maccalli. Cancer Stem Cell Resistance to Targeted Therapy. Resistance to Targeted Anti-Cancer Therapeutics 2019; 19: 223 doi: 10.1007/978-3-030-16624-3_9
|
| 119 |
Susana Mendonça Oliveira, Patrícia Dias Carvalho, André Serra-Roma, Patrícia Oliveira, Andreia Ribeiro, Joana Carvalho, Flávia Martins, Ana Luísa Machado, Maria José Oliveira, Sérgia Velho. Fibroblasts Promote Resistance to KRAS Silencing in Colorectal Cancer Cells. Cancers 2024; 16(14): 2595 doi: 10.3390/cancers16142595
|
| 120 |
Hong Li, Po Zhao, Yang Lu, Yali Lu. Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma. International Journal of Colorectal Disease 2012; 27(8): 1015 doi: 10.1007/s00384-012-1421-y
|
| 121 |
Veronica Catalano, Cecilia Eleuteri, Gaia Campoccia, Gianluca Giacobini, Mariangela Zane, Giorgio Stassi, Giorgio Parmiani, Cristina Maccalli. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Resistance to Targeted Anti-Cancer Therapeutics 2015; 7: 3 doi: 10.1007/978-3-319-17807-3_1
|
| 122 |
Hitoshi Kitamura, Koji Okudela, Takuya Yazawa, Hanako Sato, Hiroaki Shimoyamada. Cancer stem cell: Implications in cancer biology and therapy with special reference to lung cancer. Lung Cancer 2009; 66(3): 275 doi: 10.1016/j.lungcan.2009.07.019
|
| 123 |
Sirichat Kaowinn, Eun Jin Seo, Woong Heo, Jae-Ho Bae, Eun-Jung Park, Soojin Lee, Yeon Jeong Kim, Sang Seok Koh, Il Ho Jang, Dong Hoon Shin, Young-Hwa Chung. Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis. Biochemical and Biophysical Research Communications 2019; 514(4): 1278 doi: 10.1016/j.bbrc.2019.05.091
|
| 124 |
Po Zhao, Yali Lu, Weidong Han. Clinicopathological significance and prognostic value of leukemia‐related protein 16 expression in invasive ductal breast carcinoma. Cancer Science 2010; 101(10): 2262 doi: 10.1111/j.1349-7006.2010.01658.x
|
| 125 |
Mei-Mei Li, Jun Yuan, Xin-Yuan Guan, Ning-Fang Ma, Ming Liu. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits. Experimental Hematology & Oncology 2021; 10(1) doi: 10.1186/s40164-021-00246-x
|
| 126 |
|
| 127 |
Shu-Wen Jao, Su-Feng Chen, Yaoh-Shiang Lin, Yun-Ching Chang, Tsai-Yu Lee, Chang-Chieh Wu, Jong-Shiaw Jin, Shin Nieh. Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer. Annals of Surgical Oncology 2012; 19(11): 3432 doi: 10.1245/s10434-012-2394-3
|
| 128 |
Hidekazu Takahashi, Hideshi Ishii, Naohiro Nishida, Ichiro Takemasa, Tsunekazu Mizushima, Masataka Ikeda, Takehiko Yokobori, Koshi Mimori, Hirofumi Yamamoto, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori. Significance of Lgr5+ve Cancer Stem Cells in the Colon and Rectum. Annals of Surgical Oncology 2011; 18(4): 1166 doi: 10.1245/s10434-010-1373-9
|
| 129 |
Joanna Papailiou, Konstaninos J. Bramis, Maria Gazouli, George Theodoropoulos. Stem cells in colon cancer. A new era in cancer theory begins. International Journal of Colorectal Disease 2011; 26(1): 1 doi: 10.1007/s00384-010-1022-6
|
| 130 |
Wei Zhan, Xin Liao, Yuan Wang, Lianghe Li, Jin Li, Zhongsheng Chen, Tian Tian, Jingdong He. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression. Carcinogenesis 2019; 40(4): 560 doi: 10.1093/carcin/bgy144
|
| 131 |
Jung Wook Huh, Yeon Sun Park, Jae Hyuk Lee, Hyeong Rok Kim, Myung Geun Shin, Young Jin Kim. CD133 mRNA expression and microsatellite instability in colorectal carcinoma. Journal of Surgical Oncology 2010; 102(7): 765 doi: 10.1002/jso.21734
|
| 132 |
Hassan Mansour Hegab, Mahmoud S. Malis, Bassma Mohamed El-Saaba, Ahmed Samy El-Agwany, Alaa Elzarka. Cancer stem cells with positive CD44 marker in advanced malignant epithelial ovarian tumors, and their relation with chemotherapeutic sensitivity. Evidence Based Womenʼs Health Journal 2015; 5(4): 175 doi: 10.1097/01.EBX.0000471707.00703.95
|
| 133 |
Tetsuya Tamatani, Natsumi Takamaru, Go Ohe, Kazuya Akita, Takayuki Nakagawa, Youji Miyamoto. Expression of CD44, CD44v9, ABCG2, CD24, Bmi‑1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors. Oncology Letters 2018; doi: 10.3892/ol.2018.8703
|
| 134 |
Hassan Ehteram, Fatemeh Aslanbeigi, Ebrahim Ghoochani Khorasani, Mohammad Tolouee, Hamed Haddad Kashani. Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer. Oncology and Therapy 2022; 10(2): 451 doi: 10.1007/s40487-022-00205-4
|
| 135 |
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
|
| 136 |
Jing Han, Toshio Fujisawa, Syed R Husain, Raj K Puri. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-173
|
| 137 |
Kamal Shaik Fakiruddin, Nadiah Ghazalli, Moon Nian Lim, Zubaidah Zakaria, Syahril Abdullah. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour. International Journal of Molecular Sciences 2018; 19(8): 2188 doi: 10.3390/ijms19082188
|
| 138 |
A. Shikina, E. Shinto, Y. Hashiguchi, H. Ueno, Y. Naito, K. Okamoto, T. Kubo, S. Fukazawa, J. Yamamoto, K. Hase. Differential Clinical Benefits of 5-Fluorouracil-based Adjuvant Chemotherapy for Patients with Stage III Colorectal Cancer According to CD133 Expression Status. Japanese Journal of Clinical Oncology 2014; 44(1): 42 doi: 10.1093/jjco/hyt168
|
| 139 |
Ji Eun Choi, Jun Sang Bae, Myoung Jae Kang, Myoung Ja Chung, Kyu Yun Jang, Ho Sung Park, Woo Sung Moon. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance. Oncology Reports 2017; 38(3): 1695 doi: 10.3892/or.2017.5790
|